Trinity Biotech PLC
TRIB- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000888721
No open-market purchases or sales by Trinity Biotech PLC insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $379.5K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Trinity Biotech PLC changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 25 | 28 | +3 |
| Shares | 2.56M | 2.70M | +143.0K (+5.6%) |
| Value | $1.66M | $2.81M | +$1.14M (+68.7%) |
New holders (7)
Institutions that held Trinity Biotech PLC at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 39,384 | $41.0K | 0.00% |
| Captrust Financial Advisors | 27,247 | $28.3K | 0.00% |
| Commonwealth Equity Services, LLC | 12,600 | $13.0K | 0.00% |
| Two Sigma Securities, LLC | 12,247 | $12.7K | 0.00% |
| Morgan Stanley | 480 | $499 | 0.00% |
| UBS Group AG | 51 | $53 | 0.00% |
| Northwestern Mutual Wealth Management Co | 25 | $26 | 0.00% |
Sold out (4)
Institutions that held Trinity Biotech PLC at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Whitefort Capital Management, LP | 81,902 | $53.2K |
| XTX Topco Ltd | 25,751 | $17.1K |
| SBI Securities Co., Ltd. | 10 | $7 |
| Transce3nd, LLC | 3 | $2 |